3,786 research outputs found
Reversible cerebral vasoconstriction syndrome (RCVS) and headache attributed to aeroplane travel (AH): Does a link exist?
No full textThe Case of the Woman Who Did Never Dare to Fly: Headache Attributed to Imbalance between Intrasinusal and External Air Pressure
No full text
Milano consolato nell' elettione a questo arciuescouado, e promotione alla sagra porpora dell' eminentissimo Federico Visconti : colla sua solennissima entrata seguita a' 11. genaro 1682 e fontioni antecedenti /
No full textFrontispiece coat of arms of Milan, engraved by Federico Agnelli.Signatures: pi⁴ A-G⁴ H⁴(-H4).Mode of access: Internet.Binding: limp vellum. Author & title written on spine
Valutazione dell’abitudine all’uso di alcool: analisi di un campione di giovani lavoratori dell’AOU “Federico II” sottoposti a sorveglianza sanitaria.
No full textDexketoprofen trometamol in the acute treatment of migraine attack: A phase ii, randomized, double-blind, crossover, placebo-controlled, dose optimization study
No full textMigraine is a disabling disease that can significantly affect a person's quality of life. This study assessed the efficacy and tolerability of the 2 doses of dexketoprofen trometamol (DKP) compared to placebo for migraine treatment. Ninety-three patients with at least 1 migraine attack per month in the preceding 6 months were enrolled and randomized to 25 mg DKP, 50 mg DKP, and placebo in a randomized, double-blind, single-center, crossover, placebo-controlled study. Primary endpoint was pain-free episodes 2 hours after drug intake. The presence of accompanying symptoms and adverse effects was also recorded. Seventy-six patients (mean age 40.5 ± 10.9 and 61% female) completed the study. At baseline, mean number of attacks/month was 3.7 ± 1.3, with a mean duration of 15.4 ± 13.5 hours. Prevalence of pain-free episodes after drug intake was significantly reduced by 50 mg DKP vs placebo (33.8 vs 14.7%, P = .0065) whereas the dose of DKP 25 mg was better than placebo but did not reach statistical significance (23 vs 14.7%, P = .1182). Both 25 mg DKP (56.8 vs 25.3%, P = .0002) and 50 mg DKP improved headache relief compared to placebo. Furthermore, both doses of DKP increased the absence of functional disability (25 mg DKP, 39.7 vs 24%, P = .045; and 50 mg DKP, 45.9 vs 24%, P < .0004). Both doses of DKP were effective and well tolerated for acute migraine treatment
An Unsupervised Approach for Automotive Driver Identification
No full textThe adoption of on-vehicle monitoring devices allows different entities to gather valuable data about driving styles, which can be further used to infer a variety of information for different purposes, such as fraud detection and driver profiling. In this paper, we focus on the identification of the number of people usually driving the same vehicle, proposing a data analytic work-flow specifically designed to address this problem. Our approach is based on unsupervised learning algorithms working on non-invasive data gathered from a specialized embedded device. In addition, we present a preliminary evaluation of our approach, showing promising driver identification capabilities and a limited computational effort
- …
